,file,ref_number,ref_text,doi,doi_url
0,experiments/glioblastoma_survival/ai_messages/high_complexity--generated_PTEN_TP53_NF1_RB1_MGMT_medium_methylated,[1],"Stupp R, et al. 2005. New England Journal of Medicine. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma.",10.1097/01.cot.0000289242.47980.f9,https://doi.org/10.1097/01.cot.0000289242.47980.f9
1,experiments/glioblastoma_survival/ai_messages/high_complexity--generated_PTEN_TP53_NF1_RB1_MGMT_medium_methylated,[2],"Furnari FB, et al. 2007. Genes & Development. Malignant astrocytic glioma: genetics, biology, and paths to treatment.",10.1101/gad.1596707,https://doi.org/10.1101/gad.1596707
2,experiments/glioblastoma_survival/ai_messages/high_complexity--generated_PTEN_TP53_NF1_RB1_MGMT_medium_methylated,[3],"Hegi ME, et al. 2005. New England Journal of Medicine. MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma.",10.1056/nejmoa043331,https://doi.org/10.1056/nejmoa043331
